Your session is about to expire
← Back to Search
New Antibiotics vs Linezolid for Diabetic Foot Infections
Study Summary
This trial is comparing the safety and effectiveness of two different drugs to treat a serious bacterial infection.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2010 Phase 4 trial • 1225 Patients • NCT00084266Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not pregnant or breastfeeding.My foot infection is classified as moderate or severe.I have been diagnosed with diabetes (type 1 or 2).I have a severe infection or poor blood supply in my foot that might require surgery.I had an infection likely caused by bacteria not killed by certain antibiotics.I am suspected to have a bone infection.I am able to follow all study requirements and attend all scheduled events.My foot infection started or got worse in the last 2 weeks.I have never taken contezolid acefosamil or contezolid.I have a serious liver, kidney, blood, or immune system condition.My foot infection is below the knee and started at or below the ankle.
- Group 1: contezolid acefosamil/contezolid
- Group 2: linezolid
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there a high risk of negative side effects from taking contezolid acefosamil (IV)/contezolid (PO)?
"Contezolid acefosamil (IV)/contezolid (PO) has some efficacy data from Phase 3 trials and multiple rounds of safety data, so it received a score of 3."
Are there any available openings for willing test subjects?
"Yes, this clinical trial is still open and accepting patients. According to the information available on clinicaltrials.gov, the study was first posted on May 1st, 2022 and last updated on May 5th, 2022. They are looking for 865 between 1 locations."
How many individuals can enroll in this research project?
"That is correct. The clinicaltrials.gov website has the latest information on this study, which is looking for 865 participants at 1 site. The trial was first posted on 5/1/2022 and edited on 5/5/2022."
Share this study with friends
Copy Link
Messenger